Rebound of residual plasma viremia after initial decrease following addition of intravenous immunoglobulin to effective antiretroviral treatment of HIV

Lignende værker

• Reduction of the HIV-1 reservoir in resting CD4(+ )T-lymphocytes by high dosage intravenous immunoglobulin treatment: a proof-of-concept study
  af: Lindkvist, Annica, et al.
  Udgivet: (2009)
• Cells producing residual viremia during antiretroviral treatment appear to contribute to rebound viremia following interruption of treatment
  af: Aamer, Hadega A., et al.
  Udgivet: (2020)
• All-Cause Mortality and Serious Non-AIDS Events in Adults With Low-level Human Immunodeficiency Virus Viremia During Combination Antiretroviral Therapy: Results From a Swedish Nationwide Observational Study
  af: Elvstam, Olof, et al.
  Udgivet: (2020)
• HIV-1 Viral Escape in Cerebrospinal Fluid of Subjects on Suppressive Antiretroviral Treatment
  af: Edén, Arvid, et al.
  Udgivet: (2010)
• Potential Implication of Residual Viremia in Patients on Effective Antiretroviral Therapy
  af: Sahu, Gautam K.
  Udgivet: (2015)